Lobbying return by Muscular Dystrophy Society of Ireland GLC
HealthTo secure the timely assessment, pricing and reimbursement of Skyclarys (omaveloxolone) by the HSE, with a view to enabling equitable access for eligible people living with Friedreich’s ataxia in Ireland as soon as possible following completion of the relevant review and…